Product NDC: | 42549-646 |
Proprietary Name: | CYMBALTA |
Non Proprietary Name: | DULOXETINE HYDROCHLORIDE |
Active Ingredient(s): | 30 mg/1 & nbsp; DULOXETINE HYDROCHLORIDE |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 42549-646 |
Labeler Name: | STAT Rx USA LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021427 |
Marketing Category: | NDA |
Start Marketing Date: | 20040824 |
Package NDC: | 42549-646-30 |
Package Description: | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42549-646-30) |
NDC Code | 42549-646-30 |
Proprietary Name | CYMBALTA |
Package Description | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (42549-646-30) |
Product NDC | 42549-646 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | DULOXETINE HYDROCHLORIDE |
Dosage Form Name | CAPSULE, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20040824 |
Marketing Category Name | NDA |
Labeler Name | STAT Rx USA LLC |
Substance Name | DULOXETINE HYDROCHLORIDE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |